Xerosis Market Research Report- Global Forecast till 2023

Xerosis Market Research Report- Global Forecast till 2023

ID: MRFR/HC/2722-HCRR | May, 2018 | Region: Global | 90 pages | Half-Cooked Research Reports

Xerosis market information: by treatment (emollients, moisturizer, humidifier, oils, others) by causes (eczema, psoriasis, diabetes, hypothyroidism, aging, others) by end users (hospitals, dermatology clinics, home care) - Global Forecast till 2023  

Market Synopsis of global Xerosis market:
Market scenario:
Xerosis also known as xeroderma is a condition characterised by excessive dry skin caused by over cleansing, excessive showers, living in areas of low humidity, dehydration, extended exposure to sun, ageing etc. Xerosis commonly affects the scalp, lower legs, arms and thighs with symptoms such as scaling which is the visible peeling of the outer skin layer, itching, and skin cracking. Other symptoms are dry, itchy, and scaly skin, flaky skin, irritated red skin etc. Xerosis is common in the winter due to cold dry air causing the skin to lose moisture. Xerosis can also be caused by a deficiency of vitamin A, vitamin D, due to systemic illness and side effects associated with medication. The standard treatment of Xerosis is application of emollients, moisturizers etc. Xerosis also responds well to lifestyle changes. Hormonal changes due to ageing, diabetes etc. affect the sweat glands and sebaceous glands which increases the chances of Xerosis. The application of highly occlusive barriers to skin such as petrolatum, vegetable oils, mineral oil etc. provides excellent results. Lanolin, a natural lipid derived from sheep's wool, provides replacement of the natural lipids in human skin and is one of the most effective treatments for xeroderma. The main drawback of lanolin is that it is a common allergen and that it is a thick waxy substance that is difficult and inconvenient for use.

The market for Xerosis is driven by factors such as growing awareness, influence of lifestyle and fashion industry, increasing cases of skin dryness due to increasing pollution etc. The market constraints are huge number of low quality players which have fragmented the market, self-correcting nature of Xerosis etc. There is also a huge ambiguity regarding the claims of many products which is a threat to the future market. Pressure to reduce cost due to cut throat competition has forced many players especially those operating from poor regions to substitute high cost materials with lower ones often compromising on quality which has reduced the credibility of the Xerosis market for quality manufacturers. Thus the returns on advertisement are believed to fall in the future.

Considering all these factors, the market for Xerosis is expected to reach $ 9.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 5.5 % during 2017-2023.


Sources: Mayo Clinic, MRFR Analysis.

Intended Audience

  • Global Xerosis manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities

Figure 1         Global Xerosis Market by End Users, 2016 (% Market Share)


The global xerosis market is segmented on the basis of treatment, causes and end users. Based on treatment, the market has been segmented as emollients, moisturizer, humidifier, oils and others. Based on the causes, the market has been segmented as eczema, psoriasis, diabetes, hypothyroidism, aging, and others. Based on the end users, the market has been segmented as hospitals, dermatology clinics and home care.

Regional analysis
US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global xerosis. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.

Key players of Global Xerosis market:
Key players profiled in the report are Procter & Gamble, Alba Botanica, Avalon Organics, Johnson & Johnson Consumer Inc., Galderma Laboratories, Clarins, Unilever, Hempz, L’Oréal, Avon, Croda International Plc, Beiersdorf, Estee Lauder, United-Guardian, Inc., Dow Corning Corp. and others.

The report for Global Xerosis market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

1. Introduction

1.1 Definition

1.2 scope of study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations Assumptions Limitations

1.3 Market Structure:

2. Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3. Market dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4. Market factor analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

5. Global Xerosis Market, by Treatment

5.1 Emollients

5.2 Moisturizer

5.3 Humidifier

5.4 Oils

5.5 Others

6. Global Xerosis Market, By Causes

6.1 Eczema

6.2 Psoriasis

6.3 Diabetes

6.4 Hypothyroidism

6.5 Aging

6.6 Others

7. Global Xerosis Market, By End Users

7.1 Hospitals

7.2 Dermatology Clinics

7.3 Home Care

8. Global Xerosis Market, By Region

8.1 North America

8.1.1 Introduction

8.2 Europe

8.2.1 Introduction

8.3 Asia-Pacific

8.3.1 Introduction

8.4 Middle East & Africa

8.4.1 Introduction

9. Competitive landscape

9.1 Major Strategies Adopted By Market Players

9.1.1 Strategic Partnership

9.1.2 Merger & Acquisition

10. Company profile

10.1 Procter & Gamble

10.1.1 Overview

10.1.2 Product Overview

10.1.3 Financials

10.1.4 Key Developments

10.2 Alba Botanica

10.2.1 Overview

10.2.2 Product Overview

10.2.3 Financials

10.2.4 Key Developments

10.3 Avalon Organics

10.3.1 Overview

10.3.2 Product Overview

10.3.3 Financials

10.3.4 Key Development

10.4 Johnson & Johnson Consumer Inc.

10.4.1 Overview

10.4.2 Product Overview

10.4.3 Financials

10.4.4 Key Developments

10.5 Galderma Laboratories

10.5.1 Overview

10.5.2 Product Overview

10.5.3 Financials

10.5.4 Key Developments

10.6 Clarins

10.6.1 Overview

10.6.2 Product Overview

10.6.3 Financials

10.6.4 Key Developments

10.7 Unilever

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.8 Hempz

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.9 L’Oréal

10.9.1 Overview

10.9.2 Product Overview

10.9.3 Financials

10.9.4 Key Developments

10.10 Avon

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.11 Croda International Plc,

10.11.1 Overview

10.11.2 Product Overview

10.11.3 Financials

10.11.4 Key Developments

10.12 Beiersdorf

10.12.1 Overview

10.12.2 Product Overview

10.12.3 Financials

10.12.4 Key Developments

10.13 Other

11. Conclusion

11.1 Key Findings

11.1.1 From Ceo’s Viewpoint

11.1.2 Unmet Needs Of The Market

11.2 Key Companies To Watch

11.3 Prediction Of Xerosis Treatment Industry

12. Appendix